Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2003
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003CN1437601A Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
08/20/2003CN1437589A Process for the preparation of pyrazolopyrimidin ones
08/20/2003CN1118468C Pyrazolopyrimidines and pyrazolotriazines
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608192 Collections of compounds
08/19/2003US6608120 Cyclopolymerized under the influence of ultraviolet or thermal radiation; coatings or binders
08/19/2003US6608081 Treating pneumonia
08/19/2003US6608076 Treating topoisomerase I inhibitor-related disease in mammals
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608062 Ligands for gamma-aminobutyric acid receptors; treatment and/or prevention of central nervous system disorders, including anxiety
08/19/2003US6608060 Treating inflammatory diseases, destructive bone disorders, reperfusion/ischemia in stroke, myocardial ischemia, renal ischemia, cardiac hypertrophy, rheumatoid arthritis, inflammatory bowel disease, or Crohn's disease
08/19/2003CA2085620C Mono(indolylethylenyl)phthalides
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066635A1 Piperidine derivatives
08/14/2003WO2003066634A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066622A1 Novel benzimidazole compounds
08/14/2003WO2003066061A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003053941A3 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2002048154A9 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
08/14/2003US20030153756 Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
08/14/2003US20030153752 Inhibitors of serine/threonine and tyrosine kinases
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153595 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153572 Compounds and methods for the treatment of pain
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153562 Cognition activators
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153547 Polymeric micellar structure
08/14/2003US20030153546 Microbicidal effect of prophyrines in darkness
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153090 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase
08/14/2003CA2486446A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003CA2475377A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/13/2003EP1335215A1 Squarylium compounds as filters for electronic display device
08/13/2003EP1335000A2 Phthalocyanine compounds
08/13/2003EP1334973A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1178987B1 Substituted benzoylisoxazoles and the use thereof as herbicides
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0808313B1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436191A Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
08/13/2003CN1436190A Process for preparation of 2-amino-5,8-dimethoxyÒÇö1,2,4ÒÇòtriazolo ÒÇö1,5-cÒÇòpyrimidine
08/13/2003CN1435700A Electric filter for electronic display
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605630 Active against drug resistant gram positive pathogens
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605606 Solid forms of tin ethyl etiopurpurin and processes for producing such forms
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605194 Substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
08/07/2003WO2003064558A1 Fluorescent compositions comprising diketopyrrolopyrroles
08/07/2003WO2003064427A1 Tetrapyrrolic macrocycles as photodynamic agents
08/07/2003WO2003064426A1 N, n'-dimethylated n-confused porphyrins
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064424A2 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064415A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063864A2 Heterocyclic compounds which are active as inhibitors of beta lactamases
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063764A2 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/07/2003WO2002073062A3 Synthetic molecular spring device
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149042 For prophylaxis and therapy of pain or nociception
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030148926 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
08/07/2003US20030148888 Novel triazolo pyrimidine compounds
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474718A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003CA2474593A1 N, n'-dimethylated n-confused porphyrins
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2469269A1 Fluorescent compositions comprising diketopyrrolopyrroles
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/06/2003EP1333031A1 Bicyclic triazolone derivatives and herbicides containing the same
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1109811B1 Pyrrolobenzodiazepines
08/06/2003EP0768311B1 Pyrrolocarbazole derivatives
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 573